Chenfeng Wang
Chinese People's Liberation Army, Chinese PLA General Hospital
Papers
2
Total Citations
28
H-Index
2
About
Chenfeng Wang is a pioneering urologic surgeon whose work centers on the surgical management of complex renal cell carcinoma, particularly cases involving inferior vena cava (IVC) tumor thrombus. Wang’s major contributions lie in advancing robot-assisted IVC thrombectomy, a technically demanding procedure traditionally performed via open surgery. In a landmark 2020 study of 120 cases, Wang used cumulative sum analysis to define the operator learning curve for robot-assisted Mayo Clinic level I–IV thrombectomy, demonstrating that proficiency is achievable and establishing a benchmark for training. This work, cited 25 times, has helped standardize a minimally invasive approach to a life-threatening condition. More recently, Wang introduced a novel application of virtual vascular endoscopy to preoperatively identify IVC wall invasion, enabling more precise surgical planning for partial or segmental IVC resection. This innovation, detailed in a 2024 study, promises to reduce intraoperative surprises and improve oncologic outcomes. By systematically validating robotic techniques for the most challenging IVC thrombus levels, Wang has expanded the frontiers of minimally invasive urologic oncology, offering patients reduced morbidity without compromising cancer control.
Research Focus
Key Achievements
Top Papers
- 1
- 2